ESMO Public Policy Webinar on the General Data Protection Regulation and its impact on clinical research
Date: Friday 21 May 2021
Time: 13:00-15:30 CEST
The General Data Protection Regulation (GDPR) entered into force on 25 May 2016, and has been applicable since 25 May 2018, introducing important changes positively impacting the collection and use of data for all sectors including scientific research across the EU. Three years since the Regulation became applicable, and in view of the direct impact the GDPR has had on research, the European Society for Medical Oncology (ESMO) in association with the MEPs Against Cancer (MAC) Interest Group at the European Parliament, will be convening a virtual meeting on the GDPR and its impact on clinical research.
ESMO has been working on the topic of the GDPR for many years and with the support of the oncology community recently published a paper summarising the implications of the GDPR on clinical research. Thus, given the impact of the GDPR on clinical research in Europe, it is our responsibility to address this important topic, for the benefit of the oncology and health communities, and most importantly for the patients.
The virtual meeting will bring together the perspectives of EU officials and key stakeholders on this topic and facilitate a discussion on the GDPR involving the scientific research community, including the oncology community.
It is vital for us to raise awareness about this important topic and exchange views on how we as a community can work together to overcome any challenges that we may face, as a consistent interpretation of the GDPR at national levels is the only way to protect science and move research forward.
More information, including the agenda will be available shortly.
Register for the webinar here.
In association with: